General

Showing 1377–1392 of 2270 results

Article: P.17 Feasibility of next generation flow for minimal residual disease in multiple myeloma on a BD FACS Lyric flowcytometer
€3.03 Add to cart
Article: P.18 Concurrent B-cell chronic lymphocytic leukaemia and multiple myeloma
€3.03 Add to cart
Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience
€3.03 Add to cart
Article: P.19 Clonaly related monoclonal B-cell lymphocytosis and diffuse large B-cell lymphoma in a patient treated for EBV-positive Hodgkin lymphoma
€3.03 Add to cart
Article: P.19 DCEP as a salvage chemotherapy regimen for heavily pretreated multiple myeloma with intention to autograft: single center experience between 2011 and 2018
€3.03 Add to cart
Article: P.20 Crystalcryoglobulin-induced kidney disease: a case report
€3.03 Add to cart
Article: P.20 Primary Intraocular Lymphoma: a Case Report
€3.03 Add to cart
Article: P.21 Coincidence of renal cell carcinoma and post-transplant lymphoproliferative disorder following kidney transplantation
€3.03 Add to cart
Article: P.21 Disseminated nocardiosis in a patient with multiple myeloma treated with bortezomib, thalidomide and dexamethasone
€3.03 Add to cart
Article: P.22 About two cases of Merkel cell carcinoma associated with chronic lymphocytic leukaemia
€3.03 Add to cart
Article: P.22 AL amyloidosis revealed by polyarthritis
€3.03 Add to cart
Article: P.23 An aggressive, acute onset intravascular large B-cell lymphoma presenting with marked peripheral erythroblastosis: a case report
€3.03 Add to cart
Article: P.23 Heavy/light chain (HLC) and free light chain (FLC) analysis allow sensitive monitoring of multiple myeloma patients and aid detection of clonal changes
€3.03 Add to cart
Article: P.24 Neurolymphomatosis: 2 cases diagnosed with FDG PET
€3.03 Add to cart
Article: P.24 Rare morphologic phenomena in plasma cell dyscrasia: report of two cases
€3.03 Add to cart
Article: P.25 Ibrutinib-induced acrocyanosis
€3.03 Add to cart

Article: P.17 Feasibility of next generation flow for minimal residual disease in multiple myeloma on a BD FACS Lyric flowcytometer

Article: P.18 Concurrent B-cell chronic lymphocytic leukaemia and multiple myeloma

Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience

Article: P.19 Clonaly related monoclonal B-cell lymphocytosis and diffuse large B-cell lymphoma in a patient treated for EBV-positive Hodgkin lymphoma

Article: P.19 DCEP as a salvage chemotherapy regimen for heavily pretreated multiple myeloma with intention to autograft: single center experience between 2011 and 2018

Article: P.20 Crystalcryoglobulin-induced kidney disease: a case report

Article: P.20 Primary Intraocular Lymphoma: a Case Report

Article: P.21 Coincidence of renal cell carcinoma and post-transplant lymphoproliferative disorder following kidney transplantation

Article: P.21 Disseminated nocardiosis in a patient with multiple myeloma treated with bortezomib, thalidomide and dexamethasone

Article: P.22 About two cases of Merkel cell carcinoma associated with chronic lymphocytic leukaemia

Article: P.22 AL amyloidosis revealed by polyarthritis

Article: P.23 An aggressive, acute onset intravascular large B-cell lymphoma presenting with marked peripheral erythroblastosis: a case report

Article: P.23 Heavy/light chain (HLC) and free light chain (FLC) analysis allow sensitive monitoring of multiple myeloma patients and aid detection of clonal changes

Article: P.24 Neurolymphomatosis: 2 cases diagnosed with FDG PET

Article: P.24 Rare morphologic phenomena in plasma cell dyscrasia: report of two cases

Article: P.25 Ibrutinib-induced acrocyanosis